(By Balachander) A number of stocks were upgraded, downgraded and price target changed by equities research analysts on Thursday.
Endo Health Solutions Inc. (NASDAQ: ENDP): Oppenheimer downgraded the stock to "perform" from "outperform". Shares advanced 1.74 percent to trade at $32.21.
Facebook Inc. (NASDAQ: FB): Citigroup downgraded the stock to "neutral" from "buy". BMO Capital downgraded the stock to "market perform" from "outperform". Jefferies downgraded the stock to "hold" from "buy". Shares lost 1.69 percent to trade at $30.73.
JDS Uniphase Corp. (NASDAQ: JDSU): Needham upgraded the stock to "buy" from "hold". RBC Capital raised price target on the stock to $16 from $14. Shares surged 16.94 percent to trade at $14.50.
Las Vegas Sands Corp. (NYSE: LVS): Craig-Hallum downgraded the stock to "hold" from "buy". Shares jumped 6.17 percent to trade at $54.75.
Hess Corp. (NYSE: HES): UBS downgraded the stock to "neutral" from "buy". Societe Generale downgraded the stock to "hold" from "buy". Shares lost 1.30 percent to trade at $67.00.
Research In Motion Ltd. (NASDAQ: RIMM): Credit Suisse downgraded the stock to "underperform" from "neutral". Evercore reduced rating to "underweight" from "equal weight". Shares traded 4.46 percent lower at $13.15.
Qualcomm Inc. (NASDAQ: QCOM): Citigroup raised price target on the stock to $81 from $75. Goldman raised price target to $80 from $74. Piper Jaffray increased price target to $83 from $76. Shares rose 4.76 percent to trade at $66.56.